These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 10582603

  • 1. Striatal dopamine metabolism in monoamine oxidase B-deficient mice: a brain dialysis study.
    Fornai F, Chen K, Giorgi FS, Gesi M, Alessandri MG, Shih JC.
    J Neurochem; 1999 Dec; 73(6):2434-40. PubMed ID: 10582603
    [Abstract] [Full Text] [Related]

  • 2. In vivo comparison of the effects of inhibition of MAO-A versus MAO-B on striatal L-DOPA and dopamine metabolism.
    Brannan T, Prikhojan A, Martínez-Tica J, Yahr MD.
    J Neural Transm Park Dis Dement Sect; 1995 Dec; 10(2-3):79-89. PubMed ID: 9620056
    [Abstract] [Full Text] [Related]

  • 3. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I, Youdim MB, Finberg JP.
    J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
    [Abstract] [Full Text] [Related]

  • 4. Influence of selective inhibition of monoamine oxidase A or B on striatal metabolism of L-DOPA in hemiparkinsonian rats.
    Finberg JP, Wang J, Goldstein DS, Kopin IJ, Bankiewicz KS.
    J Neurochem; 1995 Sep; 65(3):1213-20. PubMed ID: 7643100
    [Abstract] [Full Text] [Related]

  • 5. Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys.
    Di Monte DA, DeLanney LE, Irwin I, Royland JE, Chan P, Jakowec MW, Langston JW.
    Brain Res; 1996 Oct 28; 738(1):53-9. PubMed ID: 8949927
    [Abstract] [Full Text] [Related]

  • 6. Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
    Ilani T, Lamensdorf I, Finberg JP.
    Br J Pharmacol; 2000 Aug 28; 130(8):1992-8. PubMed ID: 10952692
    [Abstract] [Full Text] [Related]

  • 7. Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum.
    Butcher SP, Fairbrother IS, Kelly JS, Arbuthnott GW.
    J Neurochem; 1990 Sep 28; 55(3):981-8. PubMed ID: 2117053
    [Abstract] [Full Text] [Related]

  • 8. Guinea pig striatum as a model of human dopamine deamination: the role of monoamine oxidase isozyme ratio, localization, and affinity for substrate in synaptic dopamine metabolism.
    Azzaro AJ, King J, Kotzuk J, Schoepp DD, Frost J, Schochet S.
    J Neurochem; 1985 Sep 28; 45(3):949-56. PubMed ID: 3928811
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Selective inhibition of monoamine oxidase A or B reduces striatal oxidative stress in rats with partial depletion of the nigro-striatal dopaminergic pathway.
    Aluf Y, Vaya J, Khatib S, Loboda Y, Finberg JP.
    Neuropharmacology; 2013 Feb 28; 65():48-57. PubMed ID: 22982254
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Specificity of endogenous substrates for types A and B monoamine oxidase in rat striatum.
    Schoepp DD, Azzaro AJ.
    J Neurochem; 1981 Jun 28; 36(6):2025-31. PubMed ID: 6787175
    [Abstract] [Full Text] [Related]

  • 19. Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl.
    Riederer P, Youdim MB.
    J Neurochem; 1986 May 28; 46(5):1359-65. PubMed ID: 2420928
    [Abstract] [Full Text] [Related]

  • 20. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
    Aubin N, Barneoud P, Carter C, Caille D, Sontag N, Marc C, Lolivier J, Gardes A, Perron C, Le Kim A, Charieras T, Pandini M, Burnier P, Puech F, Jegham S, George P, Scatton B, Curet O.
    J Pharmacol Exp Ther; 2004 Sep 28; 310(3):1171-82. PubMed ID: 15178694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.